Efficacy of Ultrasound-Guided Percutaneous Electrolysis for Hip Pain in Male Ice Hockey Players
Efficacy of Percutaneous Electrolysis Treatment for Hip Pain in Male Ice Hockey Players: a Pilot Study
1 other identifier
interventional
6
1 country
1
Brief Summary
Groin pain is a common and limiting condition in ice hockey players, often related to the high mechanical demands placed on the hip during skating. Repetitive movements involving hip flexion, abduction, and rotation may contribute to functional impairment and persistent symptoms. Recent clinical interest has focused on the relationship between the iliopsoas muscle and the anterior hip capsule, as their close anatomical and functional interaction may play a role in the development of hip-related groin pain. Percutaneous needle electrolysis (PNE) is a minimally invasive, ultrasound-guided technique used to promote tissue remodeling and pain reduction in musculoskeletal conditions. However, its application to the anterior hip capsule has not yet been investigated. This pilot experimental study aims to evaluate the effects of three sessions of PNE applied to the anterior hip capsule in male ice hockey players with groin pain. The main hypothesis is that this intervention may improve hip function by reducing pain and enhancing mobility and muscle strength. Outcomes include hip flexor strength, hip flexion range of motion, FADIR test results, and patient-reported outcomes measured with the HAGOS questionnaire. Assessments will be performed before and after the intervention, as well as at a 4-week follow-up.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 2, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 23, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
March 23, 2026
CompletedFirst Submitted
Initial submission to the registry
April 8, 2026
CompletedFirst Posted
Study publicly available on registry
April 14, 2026
CompletedApril 17, 2026
April 1, 2026
2 months
April 8, 2026
April 14, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Hip and groin symptoms measured with HAGOS questionnaire
Patient-reported outcomes will be assessed using the Hip and Groin Outcome Score (HAGOS), a validated questionnaire composed of six subscales: Symptoms, Pain, Activities of Daily Living, Sport and Recreation, Participation in Physical Activities, and Quality of Life. Scores range from 0 to 100, with higher scores indicating better function and fewer symptoms.
Baseline (pre-intervention), 2-3 days post-intervention, and 4-week follow-up
Hip flexor strength measured with K-Force dynamometer
Isometric maximum strength of the hip flexor muscles will be assessed using a K-Force dynamometer stabilized on a fixed support. Participants will perform maximal voluntary contractions in a standardized supine position with hip and knee flexed at 90°. Three trials will be performed, and the highest value will be recorded in kilograms (kg).
Baseline (pre-intervention), immediately post-intervention (after 3 sessions), and 4-week follow-up
Hip flexion range of motion measured with K-Move device
Passive hip flexion range of motion will be measured in degrees using a K-Move motion sensor positioned on the anterior thigh. The participant will be assessed in a supine position, and the examiner will move the limb passively until the first resistance is perceived. Three measurements will be performed, and the highest value will be recorded.
Baseline (pre-intervention), immediately post-intervention, and 4-week follow-up
FADIR test outcome (positive/negative)
The FADIR (flexion, adduction, internal rotation) test will be performed as a clinical provocation test to assess hip-related groin pain. The test will be considered positive if it reproduces the participant's typical anterior or groin pain. Results will be recorded as a dichotomous outcome (positive/negative).
Baseline (pre-intervention), immediately post-intervention, and 4-week follow-up
Study Arms (1)
Percutaneous electrolysis intervention
EXPERIMENTALParticipants will receive three sessions of ultrasound-guided musculoskeletal percutaneous electrolysis applied to the anterior capsule of the hip.
Interventions
The intervention consists of the application of ultrasound-guided musculoskeletal percutaneous electrolysis (PNE) to the anterior capsule of the hip. Under aseptic conditions, including skin disinfection, use of sterile gloves, and a disposable ultrasound probe cover, a single-use needle is inserted under real-time ultrasound guidance toward the anterior hip capsule. The needle is introduced with an oblique approach (approximately 45° relative to the skin) until reaching the target tissue. Once positioned, a controlled galvanic current is applied through the needle to induce a localized electrochemical response aimed at promoting tissue remodeling. Each participant will receive a total of three treatment sessions. The procedure is performed by a qualified clinician experienced in ultrasound-guided invasive physiotherapy techniques.
Eligibility Criteria
You may qualify if:
- Male ice hockey players (under-21 team)
- Age between 18 and 21 years
- Presence of groin pain or anterior hip pain
- Positive FADIR test
- Ability to participate in regular training activities
- Willingness to participate and provide informed consent
You may not qualify if:
- Presence of concomitant orthopedic or systemic conditions.
- Belonephobia (fear of needles).
- Contraindications to invasive physiotherapy techniques (e.g., infection, skin lesions at the treatment site, bleeding disorders, Allergies to metals.)
- Use of other concurrent treatments targeting the hip during the study period
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Veronique Vidallead
Study Sites (1)
Gottardo Arena
Ambrì, Canton Ticino, 6775, Switzerland
Study Officials
- PRINCIPAL INVESTIGATOR
Veronique Vidal, Physiotherapist
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
April 8, 2026
First Posted
April 14, 2026
Study Start
February 2, 2026
Primary Completion
March 23, 2026
Study Completion
March 23, 2026
Last Updated
April 17, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share